| Metric | FY 2021 | Prior Q | FY 2020 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.3B | — | — | — | — |
| Op. Income | $366M | — | — | — | — |
| Gross Margin | 59.1% | — | — | — | — |
| Net Margin | 20.8% | — | — | — | — |
| EPS (Diluted) | $2.75 | — | — | — | — |
| Free Cash Flow | $160M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $1.3B |
| Cost of Revenue | $532M |
| GROSS PROFIT | $768M |
| R&D Expenses | $0 |
| Selling & Marketing | $182M |
| General & Administrative | $186M |
| SG&A Expenses | $368M |
| Other Expenses | $34M |
| Operating Expenses | $402M |
| Cost & Expenses | $934M |
| OPERATING INCOME | $366M |
| Interest Income | $3M |
| Interest Expense | $2M |
| Other Income/Expenses | $10M |
| INCOME BEFORE TAX | $376M |
| Income Tax Expense | $104M |
| Net Income from Continuing Ops | $272M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $270M |
| Net Income Deductions | $2M |
| BOTTOM LINE NET INCOME | $258M |
| D&A | $30M |
| EBIT | $366M |
| EBITDA | $396M |
| EPS | $3 |
| EPS Diluted | $3 |
| Item | Amount |
|---|---|
| REVENUE | $1.3B |
| Cost of Revenue | $532M |
| GROSS PROFIT | $768M |
| R&D Expenses | $0 |
| Selling & Marketing | $182M |
| General & Administrative | $186M |
| SG&A Expenses | $368M |
| Other Expenses | $34M |
| Operating Expenses | $402M |
| Cost & Expenses | $934M |
| OPERATING INCOME | $366M |
| Interest Income | $3M |
| Interest Expense | $2M |
| Other Income/Expenses | $10M |
| INCOME BEFORE TAX | $376M |
| Income Tax Expense | $104M |
| Net Income from Continuing Ops | $272M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $270M |
| Net Income Deductions | $2M |
| BOTTOM LINE NET INCOME | $258M |
| D&A | $30M |
| EBIT | $366M |
| EBITDA | $396M |
| EPS | $3 |
| EPS Diluted | $3 |
| Item | Amount |
|---|---|
| Net Income | $272M |
| Depreciation & Amortization | $30M |
| Stock-Based Compensation | $40M |
| Deferred Income Tax | $19M |
| Other Non-Cash Items | -$178M |
| Change in Working Capital | -$13M |
| OPERATING CASH FLOW | $170M |
| Capital Expenditure | -$10M |
| Acquisitions (Net) | $27M |
| Purchases of Investments | -$9M |
| Sales/Maturities of Investments | $144M |
| Other Investing Activities | -$140M |
| NET CASH FROM INVESTING | $11M |
| Net Debt Issuance | $148M |
| Common Stock Repurchased | -$228M |
| Common Dividends Paid | -$106M |
| Other Financing Activities | -$64M |
| NET CASH FROM FINANCING | -$249M |
| FREE CASH FLOW | $160M |
| Net Change in Cash | -$71M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $233M |
| Short-Term Investments | $193M |
| Net Receivables | $96M |
| Inventory | $0 |
| Other Current Assets | $7M |
| TOTAL CURRENT ASSETS | $559M |
| PP&E (Net) | $155M |
| Goodwill | $799M |
| Intangible Assets | $471M |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $33M |
| TOTAL NON-CURRENT ASSETS | $1.5B |
| TOTAL ASSETS | $2.0B |
| Account Payables | $64M |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $27M |
| TOTAL CURRENT LIABILITIES | $271M |
| Long-Term Debt | $223M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $242M |
| TOTAL NON-CURRENT LIABILITIES | $570M |
| TOTAL LIABILITIES | $841M |
| Common Stock | $449M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $1.2B |
| Treasury Stock | -$538M |
| Accum. Other Comp. Income | $16M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.1B |
| Minority Interest | $63M |
| TOTAL EQUITY | $1.2B |
| TOTAL LIABILITIES & EQUITY | $2.0B |
| Total Debt | $346M |
| Net Debt | $113M |